Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Director comp.
CC transcript
Inv. presentation
Credit agrmnt [a]
Acq. announced
Director departure
Appointed director
Employment agrmnt

AMAG PHARMACEUTICALS, INC. (AMAG) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/24/2015 8-K/A Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits
Docs: "Consent of Independent Registered Public Accounting Firm",
"Consent of Independent Auditor",
"Unaudited pro forma condensed combined statement of operations of AMAG Pharmaceuticals, Inc. for the fiscal year ended December 31, 2014, and related notes"
01/09/2015 8-K/A Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits
Docs: "Consent of Independent Registered Public Accounting Firm",
"Consent of Independent Auditor",
"Audited consolidated balance sheets of Lumara (formerly named K-V Pharmaceutical Company) as of March 31, 2014 (Successor Company) and March 31, 2013 (Predecessor Company) and audited consolidated statements of operations, changes in stockholders' equity (deficit) and cash flows for the period September 16, 2013 to March 31, 2014 (Successor Company) and the period April 1, 2013 to September 15, 2013 (Predecessor Company) and the fiscal year ended March 31, 2013 (Predecessor Company), and related notes",
"Unaudited condensed consolidated balance sheet of Lumara as of September 30, 2014 (Successor Company) and unaudited condensed consolidated statements of operations, changes in stockholders' equity and cash flows for the six months ended September 30, 2014 (Successor Company), and the period September 16, 2013 to September 30, 2013 (Successor Company) and the period from April 1, 2013 to September 15, 2013 (Predecessor Company), and related notes",
"Unaudited pro forma condensed combined balance sheet of AMAG Pharmaceuticals, Inc. as of September 30, 2014 and unaudited pro forma condensed combined statements of operations of AMAG Pharmaceuticals, Inc. for the nine months ended September 30, 2014, and for the fiscal year ended December 31, 2013, and related notes"
12/11/2014 8-K/A Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/07/2012 8-K/A Form 8-K/A - Current report [Amend]
08/08/2011 8-K/A Form 8-K/A - Current report [Amend]
12/22/2009 8-K/A Form 8-K/A - Current report [Amend]

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy